ACHV Cytisinicline's CRL was released by FDA, and no surprises with Q426 resubmission still planned; BUY, $13 PT @ Canaccord
ACHV Cytisinicline's CRL was released by FDA, and no surprises with Q426 resubmission still planned; BUY, $13 PT @ Canaccord
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.